Statins, Tregs and cancer.

Suppr

超能文献

作者信息

Goldstein Mark R, Mascitelli Luca, Pezzetta Francesca

机构信息

9410 Fountain Medical Court, Suite A-200, Bonita Springs, FL 34135, USA.

Comando Brigata Alpina "Julia", Servizio Sanitario, 8 Via S. Agostino, Udine 33100, Italy.

出版信息

Atherosclerosis. 2008 Jan;196(1):483-484. doi: 10.1016/j.atherosclerosis.2007.09.028. Epub 2007 Oct 30.

DOI:10.1016/j.atherosclerosis.2007.09.028

PMID:17977547

Abstract

摘要

相似文献

Statins, Tregs and cancer.

Atherosclerosis. 2008 Jan;196(1):483-484. doi: 10.1016/j.atherosclerosis.2007.09.028. Epub 2007 Oct 30.

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.HMG-CoA还原酶抑制剂对天然存在的CD4+CD25+ T细胞的影响。

Atherosclerosis. 2008 Apr;197(2):829-39. doi: 10.1016/j.atherosclerosis.2007.07.031. Epub 2007 Sep 10.

Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.比较分析肝癌患者调节性 T 细胞亚群：CD25(-)FOXP3(-)T 细胞的关键作用。

Int J Cancer. 2012 Dec 1;131(11):2573-83. doi: 10.1002/ijc.27535. Epub 2012 Mar 29.

Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.肿瘤浸润的 FoxP3+ Tregs 和 CD8+ T 细胞影响肝癌患者的预后。

Digestion. 2012;86(4):329-37. doi: 10.1159/000342801. Epub 2012 Nov 28.

Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.肝内白细胞介素-17+ T细胞与叉头框蛋白3+调节性T细胞协同作用促进肝细胞癌的发展并影响其预后。

J Gastroenterol Hepatol. 2014 Apr;29(4):851-9. doi: 10.1111/jgh.12418.

Increased frequency and FOXP3 expression of human CD8CD25 T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma.肝癌患者外周血 CD8CD25T 淋巴细胞频数及其 FOXP3 表达的变化及其与 CD4 调节性 T 细胞的关系。

Hum Immunol. 2019 Jul;80(7):510-516. doi: 10.1016/j.humimm.2019.03.014. Epub 2019 Mar 20.

Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.巴塞罗那临床肝癌（BCLC）分期为B期的肝细胞癌患者外周血中CD4+CD25+FOXP3+调节性T细胞的临床预后价值

Clin Chem Lab Med. 2014 Sep;52(9):1357-65. doi: 10.1515/cclm-2013-0878.

Statins and cancer in patients with asthma.哮喘患者使用他汀类药物与癌症

Thorax. 2009 Jun;64(6):548-9; author reply 549.

Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.Foxp3+ 调节性 T 细胞与慢性乙型肝炎的自然史和肝细胞癌的不良预后相关。

Liver Int. 2012 Apr;32(4):644-55. doi: 10.1111/j.1478-3231.2011.02675.x. Epub 2011 Nov 28.

Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.慢性乙型肝炎患者体内的调节性 T 细胞通过抑制抗肿瘤免疫反应来影响肝细胞癌的免疫发病机制。

J Viral Hepat. 2010 Mar;17 Suppl 1:34-43. doi: 10.1111/j.1365-2893.2010.01269.x.

引用本文的文献

Do statins play any role in reducing the incidence and mortality of ovarian cancer? A systematic review and meta-analysis.他汀类药物在降低卵巢癌发病率和死亡率方面起作用吗？一项系统评价与荟萃分析。

J Prev Med Hyg. 2020 Oct 6;61(3):E331-E339. doi: 10.15167/2421-4248/jpmh2020.61.3.1497. eCollection 2020 Sep.

Statins as modulators of regulatory T-cell biology.他汀类药物作为调节性 T 细胞生物学的调节剂。

Mediators Inflamm. 2013;2013:167086. doi: 10.1155/2013/167086. Epub 2013 Oct 3.

The epidemic of nonmelanoma skin cancer and the widespread use of statins: Is there a connection?非黑色素瘤皮肤癌的流行与他汀类药物的广泛使用：二者有关联吗？

Dermatoendocrinol. 2010 Jan;2(1):37-8. doi: 10.4161/derm.2.1.12128.

Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance.辛伐他汀对调节性 T 细胞介导的肿瘤免疫耐受的免疫调节作用。

Clin Exp Immunol. 2010 Aug;161(2):298-305. doi: 10.1111/j.1365-2249.2010.04170.x. Epub 2010 May 18.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验